AbbVie 2014 Annual Report Download - page 33

Download and view the complete annual report

Please find page 33 of the 2014 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 182

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182

13NOV201221352027
The following table lists AbbVie’s executive officers, each of whom was first appointed as an AbbVie
corporate officer in December 2012, except as otherwise indicated.
Name Age Position
Richard A. Gonzalez 61 Chairman of the Board and Chief Executive Officer
Laura J. Schumacher 51 Executive Vice President, Business Development, External Affairs
and General Counsel
William J. Chase 47 Executive Vice President, Chief Financial Officer
Carlos Alban 52 Executive Vice President, Commercial Operations
Michael Severino, M.D.* 49 Executive Vice President, Research and Development, Chief
Scientific Officer
Timothy J. Richmond 48 Senior Vice President, Human Resources
Azita Saleki-Gerhardt, Ph.D. 51 Senior Vice President, Operations
Thomas A. Hurwich 54 Vice President, Controller
* First appointed as a corporate officer in June 2014.
Mr. Gonzalez is AbbVie’s Chairman of the Board and Chief Executive Officer. He served as Abbott’s
Executive Vice President, Pharmaceutical Products Group from 2010 to 2012, and was responsible for
Abbott’s worldwide pharmaceutical business, including commercial operations, research and development,
and manufacturing. He has also served as President, Abbott Ventures Inc., Abbott’s medical technology
investment arm, from 2009 to 2011. Mr. Gonzalez joined Abbott in 1977 and held various management
positions before briefly retiring in 2007, including Abbott’s President and Chief Operating Officer, President,
Chief Operating Officer of Abbott’s Medical Products Group, Senior Vice President and President of Abbott’s
former Hospital Products Division (now Hospira, Inc.), Vice President and President of Abbott’s Health
Systems Division, and Divisional Vice President and General Manager for Abbott’s Diagnostics Operations in
the United States and Canada.
Ms. Schumacher is AbbVie’s Executive Vice President, Business Development, External Affairs and
General Counsel. She served as Abbott’s Executive Vice President, General Counsel, and Corporate Secretary
from 2007 to 2012, and as Senior Vice President, Corporate Secretary, and General Counsel from 2005 to
2007. Ms. Schumacher was also responsible for Abbott’s licensing and acquisitions function and its Office of
Ethics and Compliance. Ms. Schumacher joined Abbott in 1990. She currently serves as a director of
General Dynamics Corporation.
Mr. Chase is AbbVie’s Executive Vice President, Chief Financial Officer. He served as Abbott’s Vice
President, Licensing and Acquisitions from 2010 to 2012, as Vice President, Treasurer from 2007 to 2010,
and as Divisional Vice President, Controller of Abbott International from 2004 to 2007. Mr. Chase joined
Abbott in 1989.
Mr. Alban is AbbVie’s Executive Vice President, Commercial Operations. He served as Abbott’s Senior
Vice President, Proprietary Pharmaceutical Products, Global Commercial Operations from 2011 to 2012, as
Senior Vice President, International Pharmaceuticals from 2009 to 2011, as Vice President, Western Europe
and Canada from 2007 to 2009, and as Vice President, European Operations from 2006 to 2007. Mr. Alban
joined Abbott in 1986.
Dr. Severino is AbbVie’s Executive Vice President, Research and Development, Chief Scientific Officer.
Dr. Severino served at Amgen Inc. as Senior Vice President, Global Development and Corporate Chief
Medical Officer from 2012 to 2014, as Vice President, Global Development from 2010 to 2012 and as Vice
President, Therapeutic Area Head, General Medicine and Inflammation Global Clinical Development from
2007 to 2012. He joined AbbVie in 2014.
2014 Form 10-K 27
EXECUTIVE OFFICERS OF THE REGISTRANT